Lanean...
Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective
Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disorder in the Western world and predominantly affects older people. Until recently, most studies in CLL focused on younger patients in whom intensive therapy with the addition of rituximab to fludarabine and cyclophosphamide...
Gorde:
| Argitaratua izan da: | Ther Adv Hematol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530370/ https://ncbi.nlm.nih.gov/pubmed/26288711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715586528 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|